Local view for "http://purl.org/linkedpolitics/eu/plenary/2012-06-13-Speech-3-609-000"

Predicate	Value (sorted: default)
rdf:type	lpv_eu:Speech2
dcterms:Date	"2012-06-13"^^xsd:date2
dcterms:Is Part Of	lp_eu:Defective silicone gel breast implants made by French company PIP (debate)2
dcterms:Language	"da"^^xsd:language2
lpv:document identification number	"en.20120613.33.3-609-000"2
lpv:hasSubsequent	lp_eu:2012-06-13-Speech-3-610-0002
lpv:speaker	lp:Margrete Auken2
lpv:spokenAs	member; PETI (2012-01-19--2014-06-30)3 substitute; Delegation to the Parliamentary Assembly of the Union for the Mediterranean (2009-09-16--2014-06-30)3 vice-chair; Delegation for relations with the Palestinian Legislative Council (2010-06-23--2014-06-30)3 unknown; Socialistisk Folkeparti (2009-07-14--2014-06-30)3 member; G/EFA (2009-07-14--2014-06-30)3 substitute; ENVI (2012-01-19--2014-06-30)3 substitute; AGRI (2012-01-19--2014-06-30)3
lpv:translated text	"Madam President, in this situation, I think it important that we manage to point out that product approval needs to be much, much better in future than it has been hitherto. That is something that we are all well aware of. I would very much like to emphasise that what particularly needs to be the case from now on is that there must be transparency, there must be openness, there must be access so that independent researchers and doctors, too, can come in and check trial data. In other words, it must be impossible, where there are human trials, for the industry to cover up the results. It must be possible, at any point in the process, to come in and evaluate the following questions. Have there been any harmful side effects? Is this actually an improvement? Is there, in fact, no improvement? Are we ripping off society by producing new devices where the old ones actually worked perfectly well already? I believe that it is absolutely crucial that we should have that transparency and I very much hope that Commissioner Dalli will support the idea of it now being the patient, the people, the citizens, who are put at the heart of things, rather than the industry. In addition, I hope that we can bring about a situation where, if there is deception with the results, which is something we have seen with the medical industry – and I am not, now, talking about the breast implants; what was done there was illegal, after all, but there can be a great deal of other deception – it must be treated as a crime, not just as something that can be sorted out by means of fines. Finally, I would like to say to my fellow Members and also to the Commission that, if the industry gets a sniff of the idea that there is a prospect of there being real, actual, true transparency and access to the unprocessed data, it will bring a highly formidable lobbying arsenal to bear against us. We will have to face all kinds of accusations of how we are destroying their opportunities, reducing chances for patients, destroying competitiveness and destroying options for research and innovation. I thus very much hope that we are able to withstand the pressure we are all going to be facing, so that we can actually come up with something about which we can hold our heads up high and that we can show to the Americans (unless we are going to adopt their system) and say that what we have come up with is even better!"@en1
lpv:videoURI	<go to Events_and_structure europarl>2

Named graphs describing this resource:

The resource appears as object in 2 triples

Context graph